A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells

We have previously demonstrated that DT-010, a novel conjugate of danshensu (DSS) and tetramethylpyrazine (TMP), displays anti-tumor effects in breast cancer cells both in vitro and in vivo. In the present study, we investigated whether DT-010 enhances the chemotherapeutic effect of doxorubicin (Dox...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Wang, Liang, Chan, Judy Y., Zhou, Xinhua, Cui, Guozhen, Yan, Zhixiang, Wang, Li, Yan, Ru, Di, Lijun, Wang, Yuqiang, Hoi, Maggie P., Shan, Luchen, Lee, Simon M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2016
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979254/
https://ncbi.nlm.nih.gov/pubmed/27559313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00249
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller